Evidence map›Paper›PMID 33865035›Full record

ReviewCurrent opinion in structural biology2021

Setting the stage for evolution of a new enzyme.

Shelley D Copley

Open access · greenAbstract readReview
In one paragraph

Review in Current opinion in structural biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Evolution of pollutant biodegradation.Applied microbiology and biotechnology · 2025
    Review
  4. Article
  5. Review
  6. Elucidating the Role of OACS environmental Au · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Protein Stability: Enhancement and Measurement.Methods in molecular biology (Clifton, N.J.) · 2023
    Article
  12. Review
  13. Article
  14. An Integrated Method to Reconstruct Ancient Proteins.Methods in molecular biology (Clifton, N.J.) · 2022
    Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Shelley D CopleyDepartment of Molecular, Cellular and Developmental Biology, The Cooperative Institute for Research in Environmental Sciences, University of Colorado Boulder, Boulder, CO, 80309, USA. Electronic address: shelley.copley@colorado.edu.
University of Colorado Boulder · US

Funding

Gene duplication and divergence: the bigger pictureR01GM134044 · NIGMS · UNIVERSITY OF COLORADO · PI COPLEY, SHELLEY D. · 2019 to 2022
$1.4M
Promiscuity, serendipity, and metabolic innovationR01GM135364 · NIGMS · UNIVERSITY OF COLORADO · PI COPLEY, SHELLEY D. · 2020 to 2023
$1.4M
NIGMS NIH HHS R01 GM134044NIGMS NIH HHS R01 GM135364
6 · The paper itself

Abstract

The evolution of novel enzymes has fueled the diversification of life on earth for billions of years. Insights into events that set the stage for the evolution of a new enzyme can be obtained from ancestral reconstruction and laboratory evolution. Ancestral reconstruction can reveal the emergence of a promiscuous activity in a pre-existing protein and the impact of subsequent mutations that enhance a new activity. Laboratory evolution provides a more holistic view by revealing mutations elsewhere in the genome that indirectly enhance the level of a newly important enzymatic activity. This review will highlight recent studies that probe the early stages of the evolution of a new enzyme from these complementary points of view.

Indexed as

Evolution, MolecularProteinsMutationProteinsAncestral reconstructionCyclohexadienyl dehydrataseEnzyme evolutionLaboratory evolutionLigninaseMetBMethyl parathion hydrolasePdxBProA

Identifiers

PMID33865035
PMCPMC8405452
OpenAlexW3154745084

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.